Annals of Surgical Oncology

, Volume 18, Issue 2, pp 580–588

mTOR Signaling is Involved in Indomethacin and Nimesulide Suppression of Colorectal Cancer Cell Growth via a COX-2 Independent Pathway

Authors

    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Yu-Jie Bao
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Qiang Dai
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Wen-Yan Yang
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Peng Cheng
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Li-Ming Zhu
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Bi-Jun Wang
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
  • Fo-Hu Jiang
    • Department of DigestionNo. 3 People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
Translational Research and Biomarkers

DOI: 10.1245/s10434-010-1268-9

Cite this article as:
Zhang, Y., Bao, Y., Dai, Q. et al. Ann Surg Oncol (2011) 18: 580. doi:10.1245/s10434-010-1268-9

Abstract

Background

Inhibition of mammalian target of rapamycin (mTOR) represents an attractive target for anticancer therapy, but its role in suppression of colorectal cancer (CRC) cell growth by cyclooxygenase-2 (COX-2) inhibitors is unclear. Here, we analyzed the effect of indomethacin (Indo, a nonselective COX-2 inhibitor) and nimesulide (Nim, a selective COX-2 inhibitor) on mTOR signaling in CRC cells in vitro and in vivo to determine the dependence of this effect on COX-2.

Methods

Human CRC cell lines with varying COX-2 expression levels were treated with Indo and Nim. Western blot test was performed to detect mTOR-related components (mTOR, p70s6 K, and 4EBP1), and cell viability, cell cycle, and apoptosis were assessed. HCT116 and SW1116 cells were injected into athymic nude mice to establish a CRC xenograft model. After treatment with Nim, tumor volume, mTOR signaling, and apoptosis were evaluated in this model. HT29 and SW1116 cells were also treated with Nim after transfection with COX-2-specific small interfering RNA (siRNA) to assess dependence of COX-2 on mTOR signaling under drug treatment.

Results

Both Indo and Nim reduced mTOR signaling activity in CRC cells that differ in their COX-2 expression in vitro and in vivo. Additionally, Indo and Nim could reduce the mTOR signaling activity after COX-2 silencing in CRC cells.

Conclusions

mTOR signaling is involved in Indo- and Nim-mediated suppression of CRC growth via a COX-2 independent pathway. This study unveils a novel mechanism through which COX-2 inhibitors exerts their anticancer effects and further emphasizes targeting mTOR signaling in anticancer therapy.

Copyright information

© Society of Surgical Oncology 2010